Arcangeli, S
(Conventional dose)Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
IJROBP 2012;84(5):1172-78
Arcangeli, S
(Hypofractionation dose)Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
IJROBP 2012;84(5):1172-78
Aoki, M
Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy)
J Radiat Res. 2014;55(3):527-32
Bahn, D
Targeted Cryoablation of the Prostate: 7_Year Outcomes in the Primary Treatment of Prostate Cancer
Urology 2002;60(2A):3-11
Berglund, RK
Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109
Urology 2012;79(3):633-37
Bittner, N
Whole pelvis radiotherapy in combination with interstitial brahytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high risk prostate cancer
IJROBP 2009;76(4):1078-1084
Bittner, N
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy
Brachytherapy 2012;11(4):250-55
Bolla, M
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911).
Lancet 2012;380(9858):2018-27
Boorjian,S
Mayo Clinic Validation of the D'Amico Risk Group Classification for Predicting Survival…
J. Urology 2008;179():1354-1361
Burri, R
Young men have equivalent biochemical outcomes compares with older men after treatment with brachytherapy for prostate cancer
IJROBP 2010;77(5):1315-21
Busch, J
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience
BJU Int 2012;110(11):E985-90
Carver, B
Long-term outcome following radical prostatectomy in men w/clinical stage T-3 prostate cancer
J. Urology 2006;176():546-568
Cohen, J
Ten-Year Biochemical Disease Control for patients with prostate cancer treated with cryosurgery as primary therapy
Urology 2008;71(3):516-518
Critz, F
10 Year disease free survival rates after simultaneous irradiation fro prostate cancer with a focus on calulation and methodology
J. Urology 2004;172():2232-2338
Critz, FA
25-year disease-free survival rate after irradiation for prostate cancer calculated with the prostat specific antigen definition of recurrences used for radical prostatectomy
J Urol 2013;189(3):878-83
Crouzet, S
Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncological outcomes and morbidity in 1002 patients
Eur Urol 2013;65(5):907-14
Dattoli, M
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features
Cancer 2007;110(3):551-555
Dattoli, M
Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Irradiation and Brachytherapy
Journal of Oncology 2010;2010():Article ID 471375 6pgs.
Dearnaley, D
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RTO1 randomised controlled trial
Lancet 2007;8():475-87
Deger, S
High dose rate brachytherapy of localized prostate cancer
European Urology 2002;41(4):420-426
Deger, S
High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer
Eur Urol 2005;47(4):441-48
Demanes, D J
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation
Am J. Clinical Oncology 2009;32(4):342-347
Feng, F
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer
IJROBP 2013;86(1):64-71
Feng, F
Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer
IJROBP 2013;86(1):64-71
Freedland, S
Radical Prostatectomy for clinical stage T3a disease
Cancer 2007;109(7):1273-78
Galalae, R
The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer- a benchmark for high-tech external beam radiotherapy alone?
Brachytherapy 2014;13(2):117-22
Galalae, R
Long-term outcome by risk factors using conformal high dose brachy boost with or without Neoadjuvant androgen suppression for localized prostate cancer
IJROBP 2004;58(4):1048-1055
Galalae, R
Hypofractionated Conformal HDR Brachytherapy in Hormone Naïve Men with Localized Prostate Cancer
Strahlentherapie und Onkologie 2006;181():135-141
Ganzer, R
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
BJU Int 2013;112(3):322-9
Guarneri, A
Radical radiotherapy in high-risk prostate cancer patients with high or ultra-high initial PDSA levels: a single institution analysis
J Ca Res Clin Oncol 2013;139(7):1141-7
Heemsbergen, W
Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local biochemical, clinical failure, and survival.
Radiother Oncol 2014;110(1):104-9
Hinnen, K
Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I125 Permanent Prostate Brachytherapy
IJROBP 2010;76(5):1433-1438
Hsu, C
Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen-deprivation therapy
BJU Int'l 2006;99():311-314
Ishiyama, H
High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up
J Radiat Res. 2014;55(3):509-17
Izard, M
Long-term outcome for prostate cancer using pseudo pulse-dosed rate brachytherapy, external beam radiotherapy, and hormones
Brachytherapy 2013;12(6):608-14
Khor, R
Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs. external beam radiation therapy alone for prostate cancer
IJROBP 2013;85(3):1679-85
Khor, R
Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs. external beam radiation therapy alone for prostate cancer
IJROBP 2013;85(3):1679-85
Kollimeier, M
Biochemical outcome after prostate brachytherapy w/5yr minimal f/up: importance of pt selection..
IJROBP 2003;57(3):645-653
Kuban, D
Long-Term Multi-Institutional Analysis of Stage T1-T2 Prostate Cancer Treated with Radiotherapy in the PSA Era
IJROBP 2003;57(4):915-928
Kuban, D
Long term results of the MD Anderson randomized dose escalation trial for prostate cancer
IJROBP 2008;70(1):67-74
Kuban, D
Long-Term Failure Patterson and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?
IJROBP 2011;79(5):1310-17
Kupelian, P
Improved Biochemical Relapse-Free Survival With Increased Radiation Doses in Patients With Locaized Prostate Cancer: The Combined Experience of Nine Institutions in 1994 and 1995
IJROBP 2005;61(2):415-419
Lau, W
Radical Prostatectomy for Pathological Gleason 8 or Greater Prostate Cancer: Influence of Concomitant Pathological Veriables
J Urology 2002;167():117-22
Loeb, S
Intermediate term potency, continence & survival outcomes of radical prostatectomy for clinically high risk or locally advanced prostate ca
Urology 2007;69(6):1170-1175
Magheli, A
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy
J Urology 2007;178():1311-1315
Marshall, R
Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center
Urol Oncol 2013;32(1):38e1-7
Mearini, L
Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
Urologia 2014;81(2):125-32
Menon, M
Biochemical Recurrence Following Robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up
Eur. Urol. 2010;58():838-46
Merrick, G
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy
BJU Int. 2011;107(2):226-232
Merrick, G
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy
BJU Int. 2011;107(2):226-232
Merrick, G
Prognostic Significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy
J. Urology 2005;66(5):1048-1053
Merrick, G
Androgen deprivation therapy dose not impact cause-specific or overall survival after permanent prostate brachytherapy.
IJROBP 2006;65(3):669-677
Merrick, G
Androgen deprivation therapy dose not impact cause specific overall survival after permanent prostate brachytherapy
IJROBP 2006;65(3):669-677
Merrick, G
Impact of Supplemental External Beam Radiotherapy and/or Androgen Deprivation Therapy on Biochemical Outcome After Permanent Prostate Brachytherapy
IJROBP 2005;61(1):32-43
Merrick, G
Impact of Supplemental External Beam Radiotherapy and/or Androgen Deprivation Therapy on Biochemical Outcome After Permanent Prostate Brachytherapy
IJROBP 2005;61(1):32-43
Mian, B
Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone
J Urology 2002;167():1675-1680
Moyad, M
STATINS, ESPECIALLY ATORVASTATIN, MAY FAVORABLY INFLUENCE CLINICAL PRESENTATION AND BIOCHEMICAL PROGRESSION-FREE SURVIVAL AFTER BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
Urology 2005;66(6):1150-1154
Mullins, JK
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
J Urol 2012;188(6):2205-10
Nguyen, Q
Long-term outcomes for men with high-risk prostate cancer treated definitively with external- beam radiotherapy with or without androgen deprivation
Cancer 2013;119(18):3265-71
Nguyen, Q
Long-term outcomes for men with high-risk prostate cancer treated definitively with external- beam radiotherapy with or without androgen deprivation
Cancer 2013;119(18):3265-71
Ohashi, T
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Radiation Oncol 2014;9():13
Pellizzon, A
The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
Int'l J. Medical Sciences 2008;5(3):113-120
Pierorazio, PM
Long-term survival after radical prstatectomy for men with high Gleason sum in pathologic specimen
Urology 2010;76(3):715-21
Pierorazio, PM
Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
BJU Int 2012;109(7):988-93
Ploussard, G
Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification
Urology 2011;78(3):607-13
Pollack, A
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer
J Clin Oncol 2013;31(31):3860-68
Potters, l
12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients With Clinically Localized Prostate Cancer
J. Urology 2005;173():1562-1566
Prada, P*
Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer
Radiation Oncol 2012;7():31-39
Prada, P*
Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer
Radiation Oncol 2012;7():31-39
Roehl, K
Cancer Progression and Survival Rates Following Anatomical Radical Retropubic Prostatectomy in 3478 Consecutive Patients: Long-Term Results
J. Urology 2004;172():910-914
Rubio-Briones, J
Metastatic progression, cancer-specific mortality and need for secondary treatments in patients with clinically high-risk prostate cancer treated initially with radical prostatectomy
Actas Urologicas Espanolas 2010;34(10):610-617
Sabolch, A
Gleason Pattern 5 is the Greatest Risk Factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation
IJROBP 2011;81(4):e351-60
Savdie, R
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse
BJU Int 2012;110(4):71-76
Savdie, R
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse
BJU Int 2012;110(4):71-76
Shilkrut, M
(EBRT)The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Cancer 2013;119(3):681-90
Shilkrut, M
(EBRT & Seeds)The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Cancer 2013;119(3):681-90
Sooriakumaran, P
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a
Minimum Follow-up Time of 5 Years
Eur Urol 2012;62(5):768-74
Spahn, M
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20ng/ml: a European multi-institutional study of 712 patients
Eur Urol 2010;58():pg 1-7
Spratt, DE
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
IJROBP 2013;85(3):686-92
Stenmark, M
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease
IJROBP 2011;81(4):e335-44
Stock, R
Outcomes for Patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy
BJU international 2009;104(11):1631-1636
Stokes, S
Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation
IJROBP 2000;47(1):129-136
Stokes, S
Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation
IJROBP 2000;47(1):129-136
Stone, Nelson
Local control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes
IJROBP 2010;76(2):355-360
Sundi, D
Very-high-risk localized prostate cancer: definition and outcomes.
Prostate Ca Prostatic Dis 2014;17(1):57-63
Sundi, D
Very-high-risk localized prostate cancer: definition and outcomes.
Prostate Ca Prostatic Dis 2014;17(1):57-63
Sylvester, J
15 yr biochemical relapse free survival after external beam radiation & brachytherapy for localized prostate ca: the Seattle Exp
IJROBP 2007;67(1):57-64
Sylvester, J
Ten yr biochemical relapse free survival after external beam radiation & brachytherapy for localized prostate ca: the Seattle Exp
IJROBP 2003;57(4):944-952
Taira, A
Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy
Brachytherapy 2013;12(5):408-14
Taira, A
Long-term outcomes for clinically localized Prostate Cancer Treated with permenent interstitial brachytherapy
IJROBP 2011;79(5):1336-42
Tendulkar, R
Redefining high-risk Prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy
IJROBP 2012;82(4):1397-1404
Thames, H
Increasing External Beam Dose for T1-T2 Prostate Cancer: Effect on Risk Groups
Int. J. Rad Onc/Bio 2006;65(4):975-981
Thomson, D
Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
Prostate Ca 2012;Epub ahead of print- June 20():
Thüroff, S
Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years
J Urol 2013;190(2):702-10
Vargas, C
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy
Brachytherapy 2013;12(2):120-5
Vora, S
Nine-year outcome and toxicity in patients treated with IMRT for localized prostate cancer
J Urol 2013;In Press(02/06/2013 00:00:00):
Ward, J
Radical Prostatectomy for Clin Adv Prostate Cancer Since the Advent of PSA Testing
BJU, Int. 2005;95(6):751-756
Yamamoto, S
Long-term Oncological Outcome and Risk Stratification in Men with High-risk Prostate Cancer Treated with Radical Prostatectomy
Jpn J Clin Oncol 2012;42(6):541-47
Yoshioka, Y
Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions
IJROBP 2011;80(2):469-475
Zelefsky, M
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
IJROBP 2007;67(2):327-333
Zelefsky, M
Long term outcome following 3-D conformal intensity modulated ext-beam radiotherapy for clinical stage T3 prostate cancer
European Urology 2008;53(6):1172-1179
Zelefsky, M
(81 Gy) Long Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer
J. Urology 2006;176():1415-1419
Zelefsky,M
(81 Gy) High Dose Radiation Delivered by Intensity Modulated Conformal Radiotherapy Improves the Outcome of Localized Prostate Cancer
J. Urology 2001;166():876-881
Zelefsky,M
(75 Gy) High Dose Radiation Delivered by Intensity Modulated Conformal Radiotherapy Improves the Outcome of Localized Prostate Cancer
J. Urology 2001;166():876-881
Zelefsky, M
(81 Gy) Long Term outcome of Conformal RT for Pca:
IJROBP 2008;71(4):1028-1033
Zelefsky, M
(86 Gy) Long Term outcome of Conformal RT for Pca:
IJROBP 2008;71(4):1028-1033